Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Obstructive

Explore clinical trials studying Lung Diseases, Obstructive. Study availability and eligibility vary by location and protocol.

8,017 public trials 743 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Obstructive trial results

Completed

Budesonide/Formoterol Inhalation Powder in Adults With Asthma

NCT07790159

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Hefei First People's Hospital Hefei, Anhui, China
  • Beijing Chao-Yang Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • China-Japan Friendship Hospital Beijing, Beijing Municipality, China
  • Peking University People's Hospital Beijing, Beijing Municipality, China
View all 28 locations
View Trial Details
Completed

Dupilumab in Type 2-Inflamed COPD Across the Full Spectrum of Airflow Limitation: An Italian Multicentre Retrospective Cohort Study

NCT07788092

Conditions
COPD, COPD (Chronic Obstructive Pulmonary Disease), Chronic Disease, +11 more
Locations
  • Azienda Ospedaliera di Perugia Perugia, Italy
  • Azienda Ospedaliera San Camillo Forlanini Roma, Italy
  • Fondazione Policlinico Universitario Campus Bio-Medico Roma, Italy
  • Ospedale Cristo Re Roma, Italy
View Trial Details
Completed

Assessing Functional Capacity in Directly and Remotely Monitored Home-based Settings: A Protocol for a Multinational Validation Study in Individuals With Chronic Respiratory Diseases

NCT06447831

Conditions
COPD Chronic Obstructive Pulmonary Disease, Chronic Disease, Disease Attributes, +8 more
Locations
  • Institut universitaire de cardiologie et de pneumologie de Québec-Université Laval Québec, Quebec, Canada
  • Groupement des Hôpitaux de l'Institut Catholique de Lille Lille, Hauts-de-France, France
  • FormAction Santé Pérenchies, Hauts-de-France, France
View Trial Details
Completed

A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

NCT06702462

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Marlton, New Jersey, United States
  • GSK Investigational Site Huntersville, North Carolina, United States
  • GSK Investigational Site San Antonio, Texas, United States
View Trial Details

Related conditions